Research Article

The Registry and Follow-Up of Complex Pediatric Therapies Program of Western Canada: A Mechanism for Service, Audit, and Research after Life-Saving Therapies for Young Children

Table 7

Selected outcomes of neonates having complex cardiac surgery for congenital heart disease followed by the Complex Pediatric Therapies Follow-up Program.

Group (years, 𝑛 )MicrocephalyWeight < 5th percentileHeight < 5th percentileCerebral palsy

ASO (1996–2004; 𝑛 = 8 8 ) [54]1.5%6.1%9.8%1.2%
TAPVC (1996-2004; 𝑛 = 3 2 ) [60]0%3%0%0%
Norwood MBTS (1996–2002; 𝑛 = 6 2 ) [58]7%17%20%0%
Norwood RVPA (2002–2005; 𝑛 = 3 2 ) [58]0%27%12%4%
IAA (1996–2006; 𝑛 = 2 7 ) [66]7.7%19%19%β€”
Deletion 22q11.2 (1996–2004; 𝑛 = 1 6 ) [7]15%8%31%β€”
Cardiac ECLS (2002–2004; 𝑛 = 3 9 ) [63]20%19%13%13%
Heart transplant under age 6 yr (1999–2006; 𝑛 = 2 9 ) [67]β€”28%31%10%

ASO: arterial switch operation for transposition of the great arteries; TAPVC: total anomalous pulmonary venous correction; MBTS: modified Blalock-Taussig shunt; RVPA: right ventricle-to-pulmonary artery shunt; IAA: correction of interrupted aortic arch; ECLS: extracorporeal life support.